[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367348-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367348-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","leptomeningeal-carcinomatosis-in-gastric-cancer-a-review","Leptomeningeal carcinomatosis in gastric cancer - A Review","","Gastric cancer ranks among the most common malignancies worldwide, and leptomeningeal carcinomatosis (LM) occurs in about 0.06% of cases. Because trials are challenging to power and regimens are heterogeneous, a review and analysis of 47 recent cases is used to guide oncologists. Diagnosis relies on CSF cytology with MRI as the preferred imaging; negative CSF findings do not exclude LM. Median survival is 2 months, with intrathecal methotrexate commonly dosed at 10–12 mg and continued until symptom resolution, negative serial cytology, CSF CEA stabilization, progression, or poor status.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/leptomeningeal-carcinomatosis-in-gastric-cancer-a-review/367348/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/leptomeningeal-carcinomatosis-in-gastric-cancer-a-review/367348.png","ImageObject",300,407,{"name":42,"@type":43},"\tJames","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How is leptomeningeal carcinomatosis in gastric cancer diagnosed?","Question",{"text":63,"@type":64},"Gold-standard diagnosis is CSF cytology. MRI is the preferred imaging modality to identify LM, and repeated lumbar punctures and imaging are often needed; negative results do not rule out LM.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What treatments are most commonly used for LM in gastric cancer?",{"text":68,"@type":64},"Treatment typically combines radiation with intrathecal chemotherapy, most commonly methotrexate. Systemic chemotherapy and immunotherapy are also used in many cases.",{"name":70,"@type":61,"acceptedAnswer":71},"What survival outcomes are reported in the review?",{"text":72,"@type":64},"Median survival was 2 months, while the maximum survival reported was 12 months.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367348,1790322860,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Gastric Cancer (2025) 28:311–325  \n[https://doi.org/10.1007/s10120-025-01597-8](https://doi.org/10.1007/s10120-025-01597-8)  \nLeptomeningeal carcinomatosis in gastric cancer: A Review  \nSimran Arjani1 · Hyein Jeon2 · Bhawneet Chadha2 · Huda Yousuf1 · Enrico Castellucci2  \nReceived: 1 July 2024 / Accepted: 1 February 2025 / Published online: 14 March 2025 © The Author(s) 2025  \nAbstract  \nGastric cancer is the fifth most common cancer worldwide and leptomeningeal carcinomatosis (LM) occurs in 0.06% of gastric cancers. As such, trials are difficult to power and quantitative analyses difficult to standardize. We composed a review and analysis of 47 recent cases to be used as a comprehensive resource for an oncologist faced with managing this highly morbid, rapidly fatal disease. Gold-standard of diagnosis of LM is through cerebral spinal fluid (CSF) cytology; MRI is the preferred imaging modality to identify LM. However, repeated lumbar punctures and imaging studies are often required to establish diagnosis. Negative results do not rule out LM. Treatment includes radiation and intrathecal chemotherapy, most commonly with methotrexate. Systemic treatment with chemotherapy and immunotherapy is also used. Median survival was 2 months. Intrathecal methotrexate was most commonly dosed at 10-12 mg and treatment continued till symptom resolution, serial lumbar punctures with negative cytology, decrease and stabilization of CSF carcinoembryonic antigen (CEA) levels, progression of disease, or poor functional status. The maximum survival was 12 months. The results of this review indicate that suspicion for leptomeningeal disease should be high in any patient with gastric malignancy or with symptoms consistent with malignancy. Treatment on a biweekly to bi-monthly basis and the addition of systemic therapy to intrathecal therapy should be studied in a matched prospective manner. And in the absence of this information, treatment with at least intrathecal chemotherapy and radiation therapy should be considered in those with a performance status conducive to continued treatment.  \nKeywords Leptomeningeal disease · Leptomeningeal metastasis · Gastric cancer · Gastric adenocarcinoma  \nAbbreviations  \nAMS  \nFND  \nMRI  \nCT  \nC/T/L spine LP  \nLM  \nAltered mental status  \nFocal neurological deficits Magnetic resonance imaging Computed tomography  \nCervical thoracic and lumbar spine Lumbar puncture Leptomeningeal disease  \n* Enrico Castellucci[ecastell@montefiore.org](ecastell@montefiore.org)  \n1 Department of Internal Medicine, Montefiore Medical Center Albert Einstein College of Medicine, 111 East 210 Street, Bronx, NY 10467, USA  \n2 Department of Oncology, Montefiore Medical Center Albert Einstein Comprehensive Cancer Center, Bronx, NY, USA  \nIntroduction  \nGastric cancer is the fifth most common cancer in the world [1], and 26,500 new cases are expected to be diagnosed in 2023 in the United States [2]. The estimated five-year relative survival of gastric cancer is 35.7% and at least 33.9% have distant spread at diagnosis [3]. Very rarely, those diagnosed with distant disease have leptomeningeal involvement. Leptomeningeal carcinomatosis (LM) has been reported to occur in 1 – 8% of all cancer patients [4] and in 5 – 15% of all stage IV cancers [5]; it is described as the involvement ofthe arachnoid mater, the pia mater, and the subarachnoid space (Fig. 1) . It most commonly occurs in breast, lung, and melanoma cancers as well as in primary CNS cancers, non-Hodgkin lymphoma, acute lymphoblastic leukemia, and multiple myeloma [4] . In gastric cancer it is exceedingly rare. Its incidence is not commonly reported as most of the published literature on this topic is composed of case reports and case series. A study from Korea published in 1999 that analyzed 8080 patients with advanced gastric carcinoma found that five patients, representing 0.06% of the patient population, had LM [6] .  \nFig. 1 Diagram specifying the leptomeninges and what is meant by","cbCaif0ZKr3UTDZA","https://ap.wps.com/l/cbCaif0ZKr3UTDZA","pdf",1078212,15,"English","# Introduction\n# Methods","[{\"question\":\"How is leptomeningeal carcinomatosis in gastric cancer diagnosed?\",\"answer\":\"Gold-standard diagnosis is CSF cytology. MRI is the preferred imaging modality to identify LM, and repeated lumbar punctures and imaging are often needed; negative results do not rule out LM.\"},{\"question\":\"What treatments are most commonly used for LM in gastric cancer?\",\"answer\":\"Treatment typically combines radiation with intrathecal chemotherapy, most commonly methotrexate. Systemic chemotherapy and immunotherapy are also used in many cases.\"},{\"question\":\"What survival outcomes are reported in the review?\",\"answer\":\"Median survival was 2 months, while the maximum survival reported was 12 months.\"}]","Leptomeningeal carcinomatosis in gastric cancer - A Review | PDF",1790170399,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0054b13157267f2b14f461892b01449.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae5c6d817cfc9860cc827a3f51c52cb5.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11db3af06e4f18fa12dc2cf372d7fe74.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce3cba6a659c5d92769e8629037652ae.webp",980,1301]